Unknown

Dataset Information

0

Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.


ABSTRACT: Hepatocellular carcinoma (HCC) results from the accumulation of deregulated tumor suppressor genes and/or oncogenes in hepatocytes. Inactivation of TP53 and inhibition of transforming growth factor-beta (TGF-?) signaling are among the most common molecular events in human liver cancers. Thus, we assessed whether inactivation of TGF-? signaling, by deletion of the TGF-? receptor, type II (Tgfbr2), cooperates with Trp53 loss to drive HCC formation. Albumin-cre transgenic mice were crossed with floxed Trp53 and/or floxed Tgfbr2 mice to generate mice lacking p53 and/or Tgfbr2 in the liver. Deletion of Trp53 alone (Trp53(KO) ) resulted in liver tumors in approximately 41% of mice by 10 months of age, whereas inactivation of Tgfbr2 alone (Tgfbr2(KO) ) did not induce liver tumors. Surprisingly, deletion of Tgfbr2 in the setting of p53 loss (Trp53(KO) ;Tgfbr2(KO) ) decreased the frequency of mice with liver tumors to around 17% and delayed the age of tumor onset. Interestingly, Trp53(KO) and Trp53(KO) ;Tgfbr2(KO) mice develop both HCC and cholangiocarcinomas, suggesting that loss of p53, independent of TGF-?, may affect liver tumor formation through effects on a common liver stem cell population. Assessment of potential mechanisms through which TGF-? signaling may promote liver tumor formation in the setting of p53 loss revealed a subset of Trp53(KO) tumors that express increased levels of alpha-fetoprotein. Furthermore, tumors from Trp53(KO) mice express increased TGF-?1 levels compared with tumors from Trp53(KO) ;Tgfbr2(KO) mice. Increased phosphorylated Smad3 and ERK1/2 expression was also detected in the tumors from Trp53(KO) mice and correlated with increased expression of the TGF-? responsive genes, Pai1 and Ctgf.TGF-? signaling paradoxically promotes the formation of liver tumors that arise in the setting of p53 inactivation.

SUBMITTER: Morris SM 

PROVIDER: S-EPMC3237853 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.

Morris Shelli M SM   Baek Ji Yeon JY   Koszarek Amanda A   Kanngurn Samornmas S   Knoblaugh Sue E SE   Grady William M WM  

Hepatology (Baltimore, Md.) 20111206 1


<h4>Unlabelled</h4>Hepatocellular carcinoma (HCC) results from the accumulation of deregulated tumor suppressor genes and/or oncogenes in hepatocytes. Inactivation of TP53 and inhibition of transforming growth factor-beta (TGF-β) signaling are among the most common molecular events in human liver cancers. Thus, we assessed whether inactivation of TGF-β signaling, by deletion of the TGF-β receptor, type II (Tgfbr2), cooperates with Trp53 loss to drive HCC formation. Albumin-cre transgenic mice we  ...[more]

Similar Datasets

| S-EPMC6923358 | biostudies-literature
| S-EPMC6139328 | biostudies-literature
| S-EPMC534514 | biostudies-literature
| S-EPMC2640227 | biostudies-other
| S-EPMC6770250 | biostudies-literature